Aurinia Pharmaceuticals Files SEC Report
Company Announcements

Aurinia Pharmaceuticals Files SEC Report

Aurinia Pharmaceuticals (AUPH) has released an update.

Aurinia Pharmaceuticals Inc. has filed a current report with the SEC, indicating routine corporate updates. The report provides details such as the company’s address, contact information, and confirmation of its common shares being traded on The Nasdaq Stock Market under the symbol AUPH.

For further insights into AUPH stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskAurinia Pharmaceuticals Announces Q2 Results Date
TipRanks Canadian Auto-Generated NewsdeskAurinia Pharmaceuticals Engages Investors at Key Conferences
TipRanks Canadian Auto-Generated NewsdeskAurinia Pharmaceuticals AGM Shareholder Decisions
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!